| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |